ORIGINAL ARTICLE
Identification of a molecular defect in a stillborn fetus with perinatal lethal hypophosphatasia using a disease-associated genome sequencing approach
 
More details
Hide details
 
Submission date: 2015-08-16
 
 
Acceptance date: 2015-10-07
 
 
Publication date: 2016-05-10
 
 
Pol J Pathol 2016;67(1):78-83
 
KEYWORDS
TOPICS
ABSTRACT
Lethal skeletal disorders represent a heterogeneous and clinically variable group of genetic conditions, usually difficult to diagnose without post-mortem radiological assessment. Here we report on a stillborn patient delivered at 22 weeks of gestation who presented with severe skeletal symptoms comprising limb shortening and intrauterine fractures detected upon prenatal ultrasound and autopsy examination. Since post-mortem X-ray was refused and no phenotypic diagnosis could be attempted, we performed next-generation sequencing (NGS) of 2741 genes associated with all known Mendelian disorders. With this strategy, we were able to demonstrate the diagnosis at a molecular level, which turned out to be perinatal lethal hypophosphatasia (HPP). This severe form of HPP represents an inborn defect of ossification often resulting in stillbirth or postnatal death. The NGS panel revealed compound heterozygous ALPL missense mutations: c.1283G>C(p.Arg428Pro) and c.1363G>A(p.Gly455Ser). Mutations detected in our case, although previously described in other patients, have not been reported to co-occur in a single individual. The diagnosis established in our index using the NGS-based approach could have been successfully reached by standard radiography. Thus, our report points to the importance of X-ray examination in stillborn cases and highlights the emerging role of NGS strategies in the diagnostic process of prenatally manifesting skeletal disorders.
REFERENCES (30)
1.
Krakow D, Lachman RS, Rimoin DL. Guidelines for the prenatal diagnosis of fetal skeletal dysplasias. Genet Med 2009; 11: 127-233.
 
2.
Mornet E, Stura E, Lia-Baldini AS, et al. Structural evidence for a functional role of human tissue nonspecific alkaline phosphatase in bone mineralization. J Biol Chem 2001; 276: 31171-31178.
 
3.
Warman ML, Cormier-Daire V, Hall C, et al. Nosology and classification of genetic skeletal disorders: 2010 revision. Am.
 
4.
J Med Genet A 2011; 155A: 943-968.
 
5.
Weiss MJ, Henthorn PS, Lafferty MA, et al. Isolation and characterization of a cDNA encoding a human liver/bone/kidney-type alkaline phosphatase. Proc Natl Acad Sci U S A 1986; 83: 7182-7186.
 
6.
Greenberg CR, Evans JA, McKendry-Smith S, et al. Infantile hypophosphatasia: localization within chromosome region 1p36.1-34 and prenatal diagnosis using linked DNA markers. Am J Hum Genet 1990; 46: 286-292.
 
7.
Whyte MP. Hypophosphatasia and the role of alkaline phosphatase in skeletal mineralization. Endocr Rev 1994; 15: 439-461.
 
8.
Narisawa S, Frohlander N, Millan JL. Inactivation of two mouse alkaline phosphatase genes and establishment of a model.
 
9.
of infantile hypophosphatasia. Dev Dyn 1997; 208: 432-446.
 
10.
Whyte MP, Landt M, Ryan LM, et al. Alkaline phosphatase: placental and tissue-nonspecific isoenzymes hydrolyze phosphoethanolamine, inorganic pyrophosphate, and pyridoxal 5’-phosphate. Substrate accumulation in carriers of hypophosphatasia corrects during pregnancy. J Clin Invest 1995; 95: 1440-1445.
 
11.
Moore CA, Curry CJ, Henthorn PS, et al. Mild autosomal dominant hypophosphatasia: in utero presentation in two families. Am J Med Genet 1999; 86: 410-415.
 
12.
Mornet E. Hypophosphatasia. Orphanet J Rare Dis 2007; 2: 40.
 
13.
Mornet E, Hofmann C, Bloch-Zupan A, et al. Clinical utility gene card for: hypophosphatasia – update 2013. Eur J Hum Genet 2014; 22. doi: 10.1038/ejhg.2013.177.
 
14.
Brun-Heath I, Lia-Baldini AS, Maillard S, et al. Delayed transport of tissue-nonspecific alkaline phosphatase with missense mutations causing hypophosphatasia. Eur J Med Genet 2007; 50: 367-378.
 
15.
Whyte MP, Leelawattana R, Reinus WR, et al. Acute severe hypercalcemia after traumatic fractures and immobilization in hypophosphatasia complicated by chronic renal failure. J Clin Endocrinol Metab 2013; 98: 4606-4612.
 
16.
Shibata H, Fukushi M, Igarashi A, et al. Defective intracellular transport of tissue-nonspecific alkaline phosphatase with an Ala162Thr mutation associated with lethal hypophosphatasia. J Biochem 1998; 123: 968-977.
 
17.
Di Mauro S, Manes T, Hessle L, et al. Kinetic characterization of hypophosphatasia mutations with physiological substrates. J Bone Miner Res 2002; 17: 1383-1391.
 
18.
Rockman-Greenberg C. Hypophosphatasia. Pediatr Endocrinol Rev 2013; 10 Suppl 2: 380-388.
 
19.
Zemojtel T, Köhler S, Mackenroth L, et al. Effective diagnosis of genetic disease by computational phenotype analysis of the disease-associated genome. Sci Transl Med 2014; 6: 252ra123.
 
20.
Robinson PN, Kohler S, Bauer S, et al. The Human Phenotype Ontology: a tool for annotating and analyzing human hereditary disease. Am J Hum Genet 2008; 83: 610-615.
 
21.
Gafnney G, Manning N, Boyd PA, et al. Prenatal sonographic diagnosis of skeletal dysplasias–a report of the diagnostic and prognostic accuracy in 35 cases. Prenat Diagn 1998; 18: 357-362.
 
22.
Doray B, Favre R, Viville B, et al. Prenatal sonographic diagnosis of skeletal dysplasias. A report of 47 cases. Ann Genet 2000; 43: 163-169.
 
23.
Nakamura-Utsunomiya A, Okada S, Hara K, et al. Clinical characteristics of perinatal lethal hypophosphatasia: a report of 6 cases. Clin Pediatr Endocrinol 2010; 19: 7-13.
 
24.
Shohat M, Rimoin DL, Gruber HE, et al. Perinatal lethal hypophosphatasia; clinical, radiologic and morphologic findings. Pediatr Radiol 1991; 21: 421-427.
 
25.
Nelson DB, Dashe JS, Donald D, et al. Fetal skeletal dyspalsias Sonographic idices associated with adverse outcomes. J Ultrasound Med 2014; 33: 1085-1090.
 
26.
Draguet C, Gillerot Y, Mornet E. Childhood hypophosphatasia: a case report due to a novel mutation. Arch Pediatr 2004; 11: 440-443.
 
27.
Spentchian M, Brun-Heath I, Taillandier A, et al. Characterization of missense mutations and large deletions in the ALPL gene by sequencing and quantitative multiplex PCR of short fragments. Genet Test 2006; 10: 252-257.
 
28.
Wenkert D, McAlister WH, Coburn SP, et al. Hypophosphatasia: Nonlethal disease despite skeletal presentation in utero (17 new cases and literature review). J Bone Miner Res 2011; 26: 2389-2398.
 
29.
Hoylaerts MF, Manes T, Millán JL. Mammalian alkaline phosphatases are allosteric enzymes. J Biol Chem 1997; 272: 22781-22787.
 
30.
Hoylaerts MF, Ding L, Narisawa S, et al. Mammalian alkaline phosphatase catalysis requires active site structure stabilization via the N-terminal amino acid microenvironment. Biochem 2006; 45: 9756-9766.
 
eISSN:2084-9869
ISSN:1233-9687
Journals System - logo
Scroll to top